搜索临床试验以:每天两次口服 200 mg 帕克替尼 (BID)
总计620个结果
-
PETHEMA Foundation完全的
-
Janssen Research & Development, LLC完全的
-
The University of The West IndiesCaribbean College of Family Physicians撤销
-
Cornerstone Pharmaceuticals终止复发/难治性急性髓性白血病美国, 西班牙, 大韩民国, 法国, 澳大利亚, 比利时, 奥地利, 德国, 波兰
-
Par Pharmaceutical, Inc.PharmaKinetics Laboratories Inc.完全的
-
Rajshekhar Chakraborty, MDGenentech, Inc.招聘中
-
Memorial Sloan Kettering Cancer CenterBoehringer Ingelheim; National Comprehensive Cancer Network完全的
-
Autifony Therapeutics LimitedUniversity of Manchester完全的
-
Clinical Hospital MerkurUniversity of Zagreb School of Medicine招聘中
-
ANRS, Emerging Infectious DiseasesUniversity of Bordeaux; PACCI Program未知新冠肺炎 | 严重急性呼吸系统综合症冠状病毒 2 | COVID-19药物治疗科特迪瓦
-
University of Texas Southwestern Medical CenterThe Rogosin Institute完全的
-
AstraZeneca主动,不招人
-
Whanin Pharmaceutical Company完全的
-
Hospital Clinic of Barcelona未知
-
Vastra Gotaland Region邀请报名
-
McLennan County Medical Education and Research...Procter and Gamble完全的
-
University of AlbertaCanadian Institutes of Health Research (CIHR); Women and Children's Health Research Institute... 和其他合作者暂停
-
Endourage, LLC撤销
-
Centocor, Inc.完全的
-
St Vincent's Hospital MelbourneMerck Sharp & Dohme LLC未知